Beam Therapeutics Inc. ($BEAM)
Filing Information
| Accession Number | 0001193125-26-138348 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 1, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
240,000
Total Value
$1,161,815.00
P&L
+inf% (+$2,180,700.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 30, 2026 | Exercise/Conversion | 25,000 | $0.67 | $16,750.00 | 1,011,667 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 30, 2026 | Sale | 25,000 | $22.37 | $559,230.00 | 986,667 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 31, 2026 | Exercise/Conversion | 25,000 | $0.67 | $16,750.00 | 1,011,667 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 31, 2026 | Sale | 25,000 | $22.76 | $569,085.00 | 986,667 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 31, 2026 | Grant/Award | 90,000 | $0.00 | $0.00 | 1,076,667 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 30, 2026 | Exercise/Conversion | 25,000 | $0.00 | $0.00 | 43,672 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 31, 2026 | Exercise/Conversion | 25,000 | $0.00 | $0.00 | 18,672 | Direct | โ | View Details |